Analysts Set The Cooper Companies, Inc. (NASDAQ:COO) Price Target at $84.77

The Cooper Companies, Inc. (NASDAQ:COO) has earned a consensus rating of “Moderate Buy” from the fifteen ratings firms that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $84.7692.

COO has been the subject of a number of research reports. JPMorgan Chase & Co. reduced their target price on shares of Cooper Companies from $76.00 to $66.00 and set a “neutral” rating for the company in a report on Thursday, August 28th. Piper Sandler reduced their price objective on Cooper Companies from $105.00 to $83.00 and set an “overweight” rating for the company in a research note on Thursday, August 28th. BNP Paribas Exane upgraded Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 target price on the stock in a report on Tuesday, July 22nd. Barclays initiated coverage on Cooper Companies in a research report on Monday, October 13th. They set an “overweight” rating and a $85.00 target price on the stock. Finally, BNP Paribas upgraded Cooper Companies from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 22nd.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $71.74 on Wednesday. Cooper Companies has a 52 week low of $61.78 and a 52 week high of $106.63. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The stock has a market cap of $14.26 billion, a PE ratio of 35.34, a price-to-earnings-growth ratio of 1.83 and a beta of 1.02. The company’s 50-day moving average price is $69.44 and its two-hundred day moving average price is $72.44.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.03. The company had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The business’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, sell-side analysts anticipate that Cooper Companies will post 3.98 EPS for the current fiscal year.

Cooper Companies announced that its board has approved a share repurchase plan on Wednesday, September 17th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the medical device company to purchase up to 15.4% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its shares are undervalued.

Insider Buying and Selling

In other news, COO Gerard H. Warner III acquired 1,450 shares of the firm’s stock in a transaction that occurred on Friday, September 5th. The stock was purchased at an average price of $69.23 per share, with a total value of $100,383.50. Following the purchase, the chief operating officer owned 18,319 shares of the company’s stock, valued at approximately $1,268,224.37. This trade represents a 8.60% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Albert G. White III acquired 10,000 shares of the stock in a transaction on Friday, September 5th. The shares were purchased at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the completion of the transaction, the chief executive officer owned 226,151 shares in the company, valued at approximately $15,466,466.89. This represents a 4.63% increase in their position. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders acquired 17,975 shares of company stock valued at $1,216,346. Company insiders own 1.98% of the company’s stock.

Institutional Trading of Cooper Companies

Several hedge funds and other institutional investors have recently modified their holdings of COO. Zions Bancorporation National Association UT purchased a new position in shares of Cooper Companies during the first quarter valued at $33,000. J.Safra Asset Management Corp grew its stake in Cooper Companies by 204.8% during the 2nd quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock valued at $36,000 after acquiring an additional 340 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new position in Cooper Companies during the 2nd quarter valued at about $36,000. GKV Capital Management Co. Inc. acquired a new position in shares of Cooper Companies in the 1st quarter valued at about $40,000. Finally, MUFG Securities EMEA plc purchased a new stake in shares of Cooper Companies in the second quarter worth approximately $42,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.